Département de santé environnementale et santé au travail, Chaire d'analyse et de gestion des risques toxicologiques et Groupe de recherche interdisciplinaire en santé, Faculté de Médecine, Université de Montréal, Québec, Canada.
J Toxicol Environ Health A. 2009;72(23):1534-49. doi: 10.1080/15287390903129481.
A longitudinal biomonitoring study was conducted to assess exposure to polycyclic aromatic hydrocarbons (PAH) in non-occupationally exposed nonsmoking adults living in the vicinity of an aluminum plant. Metabolites of several PAH (pyrene, naphthalene, chrysene, fluoranthene, benz[a]anthracene) were measured in the urine of the participants, including 1-hydroxypyrene (1-OHP) as a validated biomarker and pyrene diones as novel biomarkers. In total, 73 individuals living about 1 km away from the plant (taken as the exposed group) were compared repeatedly with 71 individuals living at least 11 km from the smelter (used as the control group). Complete first morning voids were collected twice, at a 2-wk interval, in the fall of 2005 and twice weekly for 2 consecutive weeks in the spring of 2006. Urinary biomarker concentrations were then measured by an ultra-performance liquid chromatography (UPLC) method with time-of-flight mass spectrometry detection (MS-TOF) (UPLC-MS-TOF). For most sampling days, individuals living near the plant showed significantly higher excretion values of both 1-OHP and pyrene diones (mean ratio up to 2- and 2.4-fold, respectively) than individuals living further from the plant. In the group living near the plant, geometric mean concentrations of 1-OHP varied from 0.047 to 0.058 micromol/mol creatinine, depending on the sampling day, as compared to 0.025 to 0.04 micromol/mol creatinine in the reference group. Corresponding mean values for pyrene diones were 0.017-0.056 micromol/mol creatinine and 0.014-0.039 micromol/mol creatinine, respectively. Urinary 1- and 2-naphthols were also measured as a reference and showed no significant differences between the two groups for most sampling days; metabolite concentrations of the other monitored PAH (chrysene, fluoranthene, benz[a]anthracene) were mostly below the analytical limit of detection of 0.005 to 0.01 microg/L, depending on the metabolite, with a detection rate varying from 0 to at most 21%. Individuals living near the aluminum plant thus appeared to be repeatedly exposed to higher pyrene levels than the control group, on the basis of both 1-OHP and pyrene dione excretions. However, 1-OHP concentrations observed in this first group were similar to those of other reference populations of nonsmokers studied in the past. Uptake of the other PAH associated with plant emissions was too small to significantly increase the excretion of their metabolites.
进行了一项纵向生物监测研究,以评估居住在铝厂附近的非职业性非吸烟成年人接触多环芳烃 (PAH) 的情况。研究人员测量了参与者尿液中几种 PAH(芘、萘、屈、荧蒽、苯并[a]蒽)的代谢物,包括 1-羟基芘 (1-OHP) 作为一种经过验证的生物标志物和作为新型生物标志物的芘二酮。共有 73 名居住在距离工厂约 1 公里处的人(作为暴露组)与至少居住在距离冶炼厂 11 公里处的 71 人(作为对照组)反复进行比较。2005 年秋季,两次收集完全的清晨首次排尿,间隔 2 周;2006 年春季,每周两次连续收集 2 周。然后通过超高效液相色谱 (UPLC) 法与飞行时间质谱检测 (MS-TOF)(UPLC-MS-TOF)测量尿液生物标志物浓度。对于大多数采样日,居住在工厂附近的个体的 1-OHP 和芘二酮排泄值明显高于居住在远离工厂的个体(平均值比高达 2 倍和 2.4 倍)。在居住在工厂附近的组中,1-OHP 的几何平均浓度因采样日而异,范围为 0.047 至 0.058 微摩尔/摩尔肌酐,而参考组为 0.025 至 0.04 微摩尔/摩尔肌酐。相应的芘二酮平均值为 0.017-0.056 微摩尔/摩尔肌酐和 0.014-0.039 微摩尔/摩尔肌酐。1- 和 2-萘酚也作为参考进行了测量,在大多数采样日两组之间没有显着差异;所监测的其他 PAH(屈、荧蒽、苯并[a]蒽)的代谢物浓度大多低于 0.005 至 0.01 微克/升的分析检测限,取决于代谢物,检测率为 0 至最多 21%。基于 1-OHP 和芘二酮的排泄,居住在铝厂附近的个体似乎反复暴露于高于对照组的较高芘水平。然而,在该第一组中观察到的 1-OHP 浓度与过去研究的其他非吸烟参考人群相似。与工厂排放物相关的其他 PAH 的吸收量太小,无法显着增加其代谢物的排泄。